MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
BioNano Genomics DPO Ratio 2011-2025 | BNGO
Annual DPO Ratio BioNano Genomics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104 | 158 | 195 | 177 | 187 | 146 | 56.6 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 195 | 56.6 | 146 |
Quarterly DPO Ratio BioNano Genomics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 140 | 179 | 175 | - | 54.8 | 163 | 155 | - | 189 | 199 | 242 | - | 79.3 | 57.8 | 154 | - | 151 | 112 | 110 | - | 183 | 443 | 300 | 146 | 104 | 158 | 161 | 41.3 | 40.2 | 68 | 198 | 140 | 62.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 443 | 40.2 | 150 |
DPO Ratio of other stocks in the Diagnostics research industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
125 | $ 15.75 | -7.62 % | $ 169 M |  China |
 |
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M |  USA |
 |
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
52 | $ 38.63 | 1.74 % | $ 1.07 B | USA |
 |
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
66.4 | $ 226.33 | -2.6 % | $ 165 B | USA |
 |
DarioHealth Corp.
DRIO
|
43.9 | $ 11.89 | -6.82 % | $ 337 M |  Israel |
 |
DexCom
DXCM
|
70.4 | $ 66.96 | - | $ 25.8 B | USA |
 |
IQVIA Holdings
IQV
|
126 | $ 222.26 | - | $ 40.3 B | USA |
 |
Fulgent Genetics
FLGT
|
34.9 | $ 27.14 | 0.3 % | $ 821 M | USA |
 |
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
44.2 | $ 20.56 | 3.84 % | $ 1.11 B | USA |
 |
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
1.29 K | $ 3.58 | - | $ 114 K | USA |
 |
Exact Sciences Corporation
EXAS
|
139 | $ 101.5 | - | $ 18.8 B | USA |
 |
Co-Diagnostics
CODX
|
106 | $ 0.34 | - | $ 9.98 M | USA |
 |
Guardant Health
GH
|
83.6 | $ 102.07 | - | $ 12.5 B | USA |
 |
Aspira Women's Health
AWH
|
112 | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
56.3 | $ 134.87 | - | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
24.5 | $ 193.03 | - | $ 9.92 B | USA |
 |
Quotient Limited
QTNT
|
86.2 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
18.3 | $ 182.56 | - | $ 20.3 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
33.1 | $ 264.18 | -0.21 % | $ 22.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
6.52 | $ 186.58 | - | $ 15.4 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
27 | $ 704.2 | - | $ 58.1 B | USA |
 |
Mettler-Toledo International
MTD
|
53.4 | $ 1 393.64 | - | $ 29.6 B | Schweiz |
 |
Lantheus Holdings
LNTH
|
25.3 | $ 66.62 | - | $ 4.61 B | USA |
 |
Agilent Technologies
A
|
50.1 | $ 139.68 | 0.01 % | $ 42.5 B | USA |
 |
Myriad Genetics
MYGN
|
42 | $ 7.21 | - | $ 653 M | USA |
 |
NeoGenomics
NEO
|
20.7 | $ 11.85 | - | $ 1.5 B | USA |
 |
Biomerica
BMRA
|
32.4 | $ 2.58 | - | $ 5.93 M | USA |
 |
Neogen Corporation
NEOG
|
62.7 | $ 6.86 | -2.56 % | $ 1.49 B | USA |
 |
Bioventus
BVS
|
59.2 | $ 7.55 | 1.75 % | $ 473 M | USA |
 |
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K | Israel |